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1. Introduction
Fluorescence is a ubiquitous readout of molecular localisation
in the life sciences and has enabled the elucidation of many
biological processes, particularly since the development of ge-
netically expressed fluorophores has facilitated direct observa-
tion of signalling processes in live cells. Co-localisation of dif-
ferent fluorophores via fluorescence microscopy has provided
evidence for protein interactions but this has been (diffraction)
limited to the resolution of the microscope used. Although
super-resolved imaging techniques
[1] can break this diffraction
limit, there is still a need for stronger direct evidence of pro-
tein interaction and this is afforded by Fçrster resonance
energy transfer (FRET), which only occurs between fluoro-
phores separated by less than  10 nm.
[2] As well as being
used to detect and monitor the binding of appropriately la-
belled proteins, either as an end point in fixed cells or as a dy-
namic process in live cells, FRET is also utilised in a range of
genetically expressed intracellular biosensors of which the
“Cameleon” calcium sensor
[3] is the first and best known. A
wide array of intramolecular FRET biosensors have now been
reported, reading out, for example, calcium,
[4] potassium,
[5]
chloride,
[6] GTP,
[7] IP3,
[8] PIP2
[9] and others.
[10] In addition, there
are “cleavage” sensors for which the FRET signal disappears
upon activation, such as the calpain FRET sensor for monitor-
ing calpain proteolytic activity,
[11] to complement the vast
range of intermolecular FRET readouts of protein interactions.
While there are many approaches
[12] to detect FRET, the
most widely used are probably spectral ratiometric imaging
and fluorescence lifetime imaging (FLIM). Fluorescence lifetime
measurements are particularly robust because they are usually
independent of the fluorophore concentration, the excitation
A fluorescence lifetime imaging (FLIM) technology platform in-
tended to read out changes in Fçrster resonance energy trans-
fer (FRET) efficiency is presented for the study of protein inter-
actions across the drug-discovery pipeline. FLIM provides a
robust, inherently ratiometric imaging modality for drug dis-
covery that could allow the same sensor constructs to be
translated from automated cell-based assays through small
transparent organisms such as zebrafish to mammals. To this
end, an automated FLIM multiwell-plate reader is described for
high content analysis of fixed and live cells, tomographic FLIM
in zebrafish and FLIM FRET of live cells via confocal endomi-
croscopy. For cell-based assays, an exemplar application read-
ing out protein aggregation using FLIM FRET is presented, and
the potential for multiple simultaneous FLIM (FRET) readouts
in microscopy is illustrated.
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sample absorption. Spectral ratiometric measurements have
the advantage that they are often easier to implement in
terms of instrumentation and require fewer detected photons
(and therefore shorter data acquisition times) than lifetime
measurements. Their chief drawback is that they require cali-
bration of the spectral response of the optical system, which
can include the sample itself. This calibration is usually
achieved through measurements of samples labelled with
donor only and acceptor only as well as the sample under in-
vestigation, for example.
[13] Once this is realised, spectral ratio-
metric measurements can then provide information concern-
ing the effective FRET efficiency (i.e. the product of the actual
FRET efficiency and the fraction of FRETing donor/acceptor
molecules) and the relative total numbers of donor and ac-
ceptor molecules.
[14,15] With an independent measurement of
the actual FRET efficiency of the interaction under investiga-
tion, spectral ratiometric FRET can then also provide the frac-
tions of the FRETing donor and acceptor populations. The in-
dependent measurement of FRET efficiency (positive control)
can be determined by a spectral ratiometric measurement of a
FRETing sample exhibiting the same interaction with known
stoichiometry (e.g. donor directly linked to acceptor) or by
using another method, such as acceptor photobleaching or
FLIM.
[14,15]
Fluorescence lifetime measurements are relatively robust in
the presence of spectral crosstalk, being insensitive to donor–
acceptor stoichiometry since it is only the donor fluorescence
that is measured. They therefore do not require parallel spec-
tral calibration measurements and are independent of the opti-
cal system, which makes them attractive for more challenging
biological samples such as live animal models, for which the
spectral properties can change in space and time. A determi-
nation of the mean fluorescence lifetime provides the effective
FRET efficiency and fitting fluorescence lifetime measurements
to a double-exponential decay model can provide an estimate
of both the actual FRET efficiency and the fraction of FRETing
donor population, which is suitable for quantitative assays
such as dose–response curves. It should be noted, however,
that fitting lifetime data to complex fluorescence decay
models requires significantly more detected photons than
measurements of single-exponential decay times, although this
can be mitigated for FRET by using global analysis as discussed
below. For this reason it is desirable to utilise fluorophores that
exhibit monoexponential decay profiles.
FLIM thus provides a widely applicable means to read out
FRET in order to map protein interactions and so to study cell
signalling
[16] and other processes. It can also be used to map
other variations in the local fluorophore environment, for ex-
ample utilising probes that can report on the concentration of
analytes such as calcium,
[17] or physical changes such as tem-
perature
[18] or lipid order.
[19] The robust nature of FLIM read-
outs, including of FRET, means that they may potentially be
translated along the drug-discovery pipeline from in vitro
assays to animal models. In spite of this potential, however,
FLIM has not yet made a significant impact on drug discovery.
This is at least partly due to concerns about data acquisition
times and to a lack of available instrumentation. Herein, we
present a rapid automated optically sectioning FLIM multiwell-
plate reader that we are developing for high content analysis
(HCA) and illustrate its potential with an exemplar assay for ag-
gregation of the Gag protein during the human immunodefi-
ciency virus (HIV) cycle. To illustrate the future potential, we
demonstrate the capability to simultaneously image multi-
plexed FLIM (FRET) readouts and to extend 3D FLIM and FRET
to endoscopy and tomography of disease models.
The ability to read out protein interactions using FLIM and
FRET in automated HCA could provide significant new oppor-
tunities for drug discovery and basic research, for example,
providing the opportunity to utilise siRNA libraries for screen-
ing genetic perturbations with respect to signalling networks.
A major obstacle to the application of FLIM to HCA has been
the speed of data acquisition. To date, most FLIM experiments
in cell biology have followed the first demonstration of FLIM
microscopy,
[20] and utilise time-correlated single photon count-
ing (TCSPC)
[21] implemented in a laser scanning confocal or
multiphoton microscope. While this approach provides high-
quality data, the imaging speed for this sequential pixel acquis-
ition is limited by the constraints of single photon counting
detection and by the nonlinear increase in photobleaching
and photodamage that ensues as the power of the scanning
laser beam is increased linearly. TCSPC has been implemented
in a laser scanning multiwell-plate reader
[22] but this instrument
did not acquire fluorescence lifetime images, instead delivering
a single lifetime measurement per well. Recently, an imaging
multiwell-plate reader utilising multiphoton TCSPC FLIM was
reported,
[23] but this was for secondary measurements follow-
ing identification of “hits” by steady-state polarisation-resolved
anisotropy imaging since the FLIM was considered to be too
slow for rapid measurements.
Wide-field FLIM achieves faster imaging rates than laser
scanning FLIM with lower photobleaching due to the parallel
pixel interrogation. The first demonstration of wide-field FLIM
to read microarrays was demonstrated using time-gated imag-
ing to improve the sensitivity for DNA profiling.
[24] More recent-
ly, an automated instrument for unsupervised FLIM of multi-
well-plate sample arrays was reported
[25] that exploited the fre-
quency domain (FD) fluorescence lifetime determination of
FRET in a wide-field (non-sectioned) microscope. This provided
an elegant demonstration of the potential of automated FLIM
FRET and the opportunities afforded by statistical analysis of
such FLIM array data. More recently, a wide-field FD FLIM plate
reader has been applied to image post-translational modifica-
tions (tyrosine phosphorylation) in situ—specifically uncover-
ing components that transduce signals from epidermal growth
factor receptor.
[26] While these wide-field FD FLIM instruments
have been successful, they can be limited in signal-to-noise
ratio by the lack of optical sectioning, which improves quanti-
tative readouts by rejecting contributions from out-of-focus
fluorescence (as is inherent in laser scanning confocal/multi-
photon systems). FD FLIM systems can also be limited in speed
by the need for sufficient temporal sampling of the fluores-
cence signal to avoid aliasing artefacts that can arise from
pulsed excitation or nonlinearities in the excitation/detection
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using special demodulation functions, as in the technique of
f
2 FLIM.
[15]
We recently demonstrated that wide-field time-gated imag-
ing using a gated optical intensifier (GOI) can be combined
with a Nipkow disc confocal microscope to provide high-speed
optically sectioned FLIM that is significantly faster, for a given
signal-to-noise ratio (S/N), than current TCSPC instrumentation.
With this instrument we demonstrated the acquisition of time-
gated FLIM FRET images of live cells labelled with FRET con-
structs at up to 10 frames per second.
[27] Although wide-field
time-gated FLIM generally yields a lower S/N ratio per photon
emitted by the sample than TCSPC, the parallelism provides a
greater S/N per unit acquisition time, which is important for
studying dynamics and for higher-throughput applications.
Wide-field time-gated imaging can facilitate FLIM with as few
as three time-gates for monoexponential and five for double-
exponential decay models in the presence of a background
contribution. We previously published the first report of an au-
tomated high-speed optically sectioned FLIM multiwell-plate
reader for HCA,
[28] by utilising time-gated imaging via a home-
built Nipkow disc microscope for automated (unsupervised)
FLIM FRET with acquisition times of less than 10 s per well in-
cluding sample motion, autofocus, cell finding and system cali-
bration (or less than 16 min/96-well plate), and demonstrated
its application to fixed and live cell imaging. Herein, we dem-
onstrate that this approach can be implemented on a commer-
cial wide-field multiwell-plate reader (GE Healthcare IN Cell An-
alyzer 1000) typically acquiring optically sectioned FLIM images
in a few seconds and automatically reading a 96-well plate in
 10 min, within which time we typically acquire several hun-
dred photons per pixel.
Our in-house software controls the automated image acquis-
ition and data analysis, including image segmentation and
global analysis. Approximately 300 photons are sufficient to fit
a fluorescence decay profile to a monoexponential decay
model but not to more complex models. For many applica-
tions it is still useful to fit complex fluorescence decays to a
monoexponential model and use the change in effective life-
time as an indicator, for example, of FRET. Alternatively, one
can obtain more detailed information by applying global anal-
ysis to the same data. The simplest approach is global binning,
which involves binning all the detected photons from a region
of interest (ROI) and fitting the composite signal to, for exam-
ple, a double-exponential decay model, to determine the fluo-
rescence lifetime components under the assumption that the
lifetimes are invariant across the ROI. This can be combined
with automatic image segmentation to define the regions of
interest. A more sophisticated approach is to apply global fit-
ting,
[29] which again assumes that the component lifetimes are
invariant across the image but here the entire image data set
is fitted in parallel to the model by minimising a global c
2.
Global fitting is computationally intensive and so is normally
applied in post-processing, while more immediate readouts
are typically provided by fitting to a monoexponential decay
model or by using analytical approaches such as rapid lifetime
determination
[30] or phasor analysis.
[31,32] Phasor analysis can
also be applied to FLIM FRET data and provides useful graphi-
cal representations with no need for iterative fitting. It can be
extended to include a “cluster-style” analysis of the phasor plot
distribution that allows the signal at each pixel to be decom-
posed into FRETing and non-FRETing components, thus allow-
ing the stoichiometry at each pixel to be determined.
[32] Phasor
analysis and global fitting techniques make the same basic as-
sumption that the signal from each pixel can be described as a
linear sum of two spatially invariant decay profiles. Phasor
analysis imposes lower computational and memory require-
ments than global analysis, but a quantitative comparison of
the information content, signal-to-noise performance and
degree of bias for these two different approaches under practi-
cal experimental conditions has, to the best of our knowledge,
not yet been undertaken.
The optically sectioning multiwell-plate reader described is
being developed for FLIM and FRET assays and here we discuss
its performance, including with respect to an exemplar applica-
tion concerning the aggregation of HIV-1 Gag proteins in the
late life cycle of the HIV-1 virion.
[33,34] HIV-1 Gag is the major
structural protein within HIV-1 virions and is thought to inter-
act with other viral proteins, the viral genome and with a large
number of host cell factors, to orchestrate the formation of
new virions at the plasma membrane of the target cell.
[35] The
expression of HIV-1 Gag alone within living cells leads to the
formation of virus-like particles (VLPs), which provides a con-
venient means to study this late stage of the HIV cycle. By tag-
ging HIV-1 Gag with either cyan fluorescent protein (CFP) or
yellow fluorescent protein (YFP) at its C terminus, we are able
to read out oligomerisation using FLIM FRET since co-transfec-
tion of Gag–CFP and Gag–YFP results in the production of
VLPs that undergo FRET from Gag–CFP to Gag–YFP due to the
close packing of Gag proteins within newly formed VLPs. While
FRET has previously been used to monitor clustering of Gag
proteins in this context,
[36–38] we believe that this is a useful
test of the utility of our new Nipkow FLIM multiwell-plate
reader, noting that previous work was confined to confocal mi-
croscopy. The application of an automated FLIM plate reader
could permit the screening of compounds designed to inter-
fere with this important stage in the HIV life cycle.
For drug discovery, an automated FLIM multiwell-plate
reader can be used to apply FRET to read out protein–protein
interactions that can report on the impact of drug candidates
on a cell-signalling network. While this is already a significant
advance on the state of the art, such readouts would be more
specific and informative if multiple components of cell-signal-
ling networks could be probed simultaneously. Spectral ratio-
metric imaging has previously been used to simultaneously
map two separate FRET readouts,
[39,40] but the spectral cross-
talk remains a challenge when using this approach. To address
this issue, we previously
[41] multiplexed a FLIM FRET readout of
Ras-Raf protein binding, using TagRed/mPlum as the donor–ac-
ceptor pair, with a spectral ratiometric readout of a “Cameleon”
FRET probe
[3] utilising CFP/YFP, to demonstrate simultaneous
monitoring of two components of the epidermal growth factor
(EGF) signal pathway in live COS-7 cells. We believe that this
combination of fluorophores is widely applicable and offers
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ed. Unlike ratiometric approaches to FRET, FLIM is able to
make use of relatively dim acceptors such as mPlum—or even
dark acceptors
[42]—since only measurement of the donor is re-
quired. Indeed, the use of dark acceptors is desirable for FLIM
FRET and can enable a higher density of multiplexed readouts.
This earlier work was limited to wide-field microscopy by the
equipment then available to us. We have now demonstrated
an optically sectioned multiplexed FLIM microscope based on
the approach of our earlier work
[41] but using a Nipkow disc
unit incorporating an electronically controlled dichroic changer
and electronically controlled excitation and emission filter
wheels. This enables interleaved FLIM acquisitions in two spec-
tral channels, thus permitting the spatiotemporal mapping of
two fluorescence lifetime readouts. For a first demonstration of
this capability, we have simultaneously imaged the calcium
transients induced in HEK293T cells following the addition of
ionomycin using both a genetically expressed calcium sensor,
Troponin TN-L15
[43] labelled with CFP/Citrine, and a calcium-
sensitive dye, GFP-Certified FluoForte (Enzo Life Sciences Ltd,
UK). In the future we hope to implement multiplexed FLIM
readouts on our multiwell-plate reader.
There is increasing concern that biological processes ob-
served in monolayers of cultured cells are not necessarily re-
produced in live model organisms, or human patients. This is
of crucial importance to drug discovery and testing, but practi-
cal constraints—particularly the desire for convenient read-
outs—have nevertheless led most assays to be undertaken in
conditions that are far removed from their native or intended
physiological contexts. This has been particularly true of opti-
cal readouts, which have been widely used in high-throughput
screening, but now there is an increasing trend to translate
assays from cell monolayers to “more realistic” 3D cell and
tissue cultures, to transparent live organisms that are amena-
ble to genetic manipulation such as drosophila and zebrafish,
and to small mammals. Imaging plays an important role in
assays for such disease models although, to date, most of the
readouts have been concerned with morphology and ultimate
phenotypes, which can be difficult to directly correlate with
cellular responses. We aim to translate FLIM and FRET along
the drug-discovery pipeline and image functional changes in
signalling networks that can be directly correlated with cell-
based assays using the same readouts.
To this end we are developing tomographic FLIM instrumen-
tation based on the technique of optical projection tomogra-
phy (OPT),
[44] which is analogous to X-ray computed tomogra-
phy but uses visible radiation rather than X-rays and so re-
quires the samples to be more or less transparent. This is usu-
ally achieved using a chemical clearing process that eliminates
the scattering of visible radiation by refractive index matching
throughout the sample using BABB (a 1:2 mixture of benzyl al-
cohol and benzyl benzoate) or other index-matching solutions.
Our “tomoFLIM” approach utilises wide-field time-gated fluo-
rescence imaging combined with a rotating sample stage. Re-
construction of 3D transmission and fluorescence images of
transparent samples is realised using standard back-projection
techniques to produce a series of time-gated images generat-
ed as a function of time delay after excitation. This can be pro-
cessed to give 3D fluorescence intensity and lifetime distribu-
tions, which, in turn, can be used to map FRET in 3D through-
out a sample. To date, we have demonstrated the ability to
map FLIM in 3D in chemically cleared mouse embryos
[45] and
have demonstrated 3D FLIM of FRET in transparent phantoms.
The prospect of reading out FRET-based assays using tomo-
FLIM in disease models such as zebrafish offers many opportu-
nities in drug discovery, including lead validation and toxicolo-
gy studies, as well as for molecular cell biology in general, but
there remain some significant hurdles. The need for chemical
clearing precludes the use of live samples and, unfortunately,
the chemical clearing process itself appears to degrade the
fluorescence of genetically expressed fluorescent proteins.
[46]
Very recently, however, we have succeeded in applying tomo-
FLIM to a fixed but not cleared zebrafish embryo labelled with
enhanced green fluorescent protein (EGFP). This is an impor-
tant step towards our ultimate goal of imaging live zebrafish.
Having identified drug candidates using cell-based assays, it
is necessary to evaluate their performance, for example with
respect to efficacy and toxicology, in animal models such as
mice. Unfortunately such animals are far from transparent but
the prospect of translating cell-based assays to animal models
is stimulating increasing interest in addressing this challenge.
Our tomoFLIM set-up can also be applied to imaging scatter-
ing samples but then the image reconstruction cannot be real-
ised using back projection. Instead, it is necessary to take into
account the multiple scattering of the detected photons and
to use statistical diffuse light propagation algorithms to recon-
struct the 3D fluorescence quantum efficiency and lifetime dis-
tributions based on the probable trajectories of the detected
photons. Unlike OPT, which can deliver diffraction-limited
images, diffuse fluorescence tomography (DFT) provides signif-
icantly decreased spatial resolution. Nevertheless, we have
shown that DFT is able to reconstruct fluorescence lifetime dis-
tributions in scattering phantoms.
[47] If the technique can be
extended to live samples, such as genetically manipulated
mice, then it would provide a further opportunity to correlate
FLIM-based readouts, for example of cell-signalling networks,
across the drug-discovery pipeline. We note that tomographic
FLIM in diffuse media has received considerable attention re-
cently, particularly with respect to the development of appro-
priate reconstruction algorithms (see, e.g., ref. [48]), but tomo-
graphic FLIM of FRET in a live subject is still yet to be reported.
For many investigations, it would be valuable to also obtain
morphological information and to be able to image cell bio-
logical processes in vivo in live disease models, such as mice,
with subcellular resolution. This can be realised using intravital
microscopy, as is, for example, undertaken in neurological
studies in live rodents,
[49] or by using endoscopy. Although we
believe that FLIM endoscopy provides a promising route to
study signalling processes and disease mechanisms in vivo, as
well as providing a new molecular imaging modality for clinical
diagnosis, we note that there have been few reports of FLIM
endoscopes since the first demonstration of FD FLIM applied
to ex vivo and in vivo tissue imaging.
[50] In the time domain,
we have demonstrated wide-field time-gated FLIM in rigid
[51]
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[52] endoscopes and note that, in general, the larger
achievable fields of view and imaging speeds may make wide-
field FLIM endoscopes more suitable for clinical diagnostic
(screening) applications than laser scanning instruments, al-
though the latter can provide optical sectioning and subcellu-
lar resolution to study signalling processes. For the latter appli-
cation, we developed the first confocal laser scanning FLIM en-
domicroscope, which provides optically sectioned subcellular
resolution that we applied to tissue autofluorescence and FRET
in fixed cells.
[53] We are not aware of any reports of multipho-
ton FLIM endoscopy but we note that multiphoton FLIM has
been extensively used for intravital imaging of skin (see, e.g.,
ref. [54]) and has been applied to FRET studies of Alzheimer’s
disease.
[55]
Our confocal FLIM endoscope is based on a commercially
available endomicroscope
[56] (Cellvizio GI, Mauna Kea Technolo-
gies) to which we have added an ultrafast excitation laser and
TCSPC detection to facilitate FLIM, thus realising acquisition
times of a few seconds. This approach enables endoscopic
confocal FLIM via a range of optical-fibre-bundle probes that
either work in a “contact” imaging mode (i.e. working depth
0 mm) or use distal micro-optics to achieve optically sectioned
imaging at a fixed working depth (e.g. from 20 to 80 mm). Sub-
sequently a similar instrument, albeit limited to “contact imag-
ing”, was demonstrated for FLIM of FRET in live cells immobi-
lised in a gel-based matrix, and reporting FLIM acquisition
times of 300 s.
[57] Our earlier system
[53] was assembled on a
large optical table in a physics laboratory and we now describe
a refined prototype intended for clinical imaging and animal
experiments that is developed for integration into a trolley of
area 70 100 cm
2. To illustrate its potential for in vivo FLIM
FRET studies, we applied it to live cells expressing EGFP and
mCherry, either separately or joined by a short peptide linker
to provide a FRET sample. Unambiguous FLIM FRET readouts in
these live cells were obtained with acquisition times of a few
seconds. To provide a real-time FLIM preview mode to guide
clinicians and experimenters, we are now working to imple-
ment the first in, first out (FIFO) mode of TCSPC acquisition,
which will also permit acquisition of larger image data sets. We
note that the “time-tagged” photon detection associated with
FIFO TCSPC will potentially enable us to use image registration
techniques if FLIM of samples moving within the total acquisi-
tion time is required. We are also working on FLIM montaging
techniques to combine multiple fields of view in a single data
set.
2. Results and Discussion
2.1. HCA in an Optically Sectioned FLIM Multiwell-Plate
Reader
FLIM multiwell-plate readers may potentially be exploited for
FRET and drug discovery and it is important to characterise
their performance. For this purpose, we undertook a range of
experiments applying our modified IN Cell Analyzer 1000 in-
strument to various dye and cell samples. Figure 1a shows the
map of a multiwell plate containing mixtures of the dyes Rho-
damine B and Rhodamine 6G in various ratios, which we
imaged by acquiring FLIM images from four fields of view per
well. As a way of initially visualising the data, we fitted a
single-exponential decay model to all pixels acquired from
each well and then calculated the mean lifetime for that well
(see Figure 1b). We then used two double-exponential decay
analysis methods to illustrate the capability to determine the
ratio of different fluorophore components, as illustrated in Fig-
Figure 1. a) Plate map of mixtures of Rhodamine B and Rhodamine 6G (Rho-
damine B percentage shown). b) False-colour fluorescence lifetime map of
the mean of the lifetime histograms produced from per-pixel fitting with a
single-exponential decay model. c) Histograms of percentage of Rhoda-
mine B determined by per-pixel fitting to a double-exponential model (solid
curves) and a global double-exponential fit to a subset of the data (dashed
curves); [P]=predefined, [G]=global.
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Rhodamine B and Rhodamine 6G from the 100 and 0% Rhoda-
mine B wells, respectively, by taking the mean of a single-expo-
nential fit to each image pixel. We then performed a double-
exponential fit to each pixel using all of the pixels from a par-
ticular dye ratio (i.e. over 16 4 FLIM data sets), with the two
lifetimes fixed to the values determined in the previous step.
The resulting histograms of the percentage of Rhodamine B
decay component are shown as the solid curves in Figure 1c.
In the second method, we took a subset of the data consisting
of one FLIM image per dye ratio (i.e. six images) and used
global double-exponential fitting to analyse all of the pixels in
the data sets simultaneously. The use of a subset of the data
for the global fitting was due to computer memory constraints
for the global fitting algorithm (see the dashed curves in Fig-
ure 1c).
The ability to resolve small fluorescence lifetime differences
was also investigated using a dye, trans-4-[4-(dimethylamino)-
styrl]-1-methylpyridinium iodide (DASPI), the fluorescence life-
time of which is known to vary with the solvent viscosity.
[58,59]
Figure 2 shows the variation of the mean fluorescence lifetime
per well (calculated by fitting pixel-wise to a monoexponential
decay model and then taking the mean of the resulting histo-
gram) obtained for DASPI dissolved in a series of composite
solvents comprising mixtures of ethanol and glycerol ranging
from 40% to 80% glycerol. The temporal instrument response
function (IRF) used for this fit was determined using the atte-
nuated excitation laser to directly illuminate the gated intensi-
fier. Figure 2 illustrates that, while our FLIM multiwell-plate
reader was set to acquire data with a gate width of 2000 ps, it
can be used to measure the fluorescence decay of fluoro-
phores with much shorter lifetimes, due to the steep edges of
the gated optical intensifier (GOI) time-gate, and can distin-
guish lifetime differences less than  20 ps. We note that the
fluorescence lifetime of DASPI dissolved in water is less than
150 ps, as determined from cuvette-based measurements
using our home-built fluorometer,
[60] and DASPI thus provides
a convenient means to obtain an IRF for a range of FLIM in-
strumentation.
To characterise the performance of this FLIM multiwell-plate
reader with live cells, we produced three multiwell plates con-
taining HEK293T cells expressing EGFP only, an EGFP–mCherry
tandem FRET construct and a mixture of EGFP and the EGFP–
mCherry construct. Figure 3 shows maps of the mean fluores-
cence lifetime across each well (with lifetimes averaged over
up to three fields of view within a well) and exemplar fluores-
cence lifetime images (for which the false-colour lifetime map
has been merged with the fluorescence intensity map) for 96-
well plates presenting cells transfected with EGFP only (Fig-
ure 3a), both EGFP and the EGFP–mCherry construct (in an un-
known stoichiometry; Figure 3b) and only the EGFP–mCherry
construct (Figure 3c). It should be noted that the fluorescence
lifetime colour scale used for the mean lifetime maps has been
optimised for maximum contrast and is not the same as that
used for the fluorescence lifetime images. In each case the
data from each pixel were fitted to a monoexponential decay
model using an IRF obtained by imaging DASPI in ethanol. For
each labelling configuration, Figure 3d shows the correspond-
ing fluorescence lifetime histograms for all the wells from each
well plate and for a single representative well from each of the
well plates. The small difference between the solid and dotted
histograms indicates the relatively low inter-well variation in
our measurements. The larger difference between the single-
well and multiwell histograms for the EGFP–mCherry construct
may be due to the presence of incomplete and/or immature
mCherry protein in some cells in the multiwell plate. The blank
wells are those where the multiwell-plate reader failed to find
sufficient cells to image and hence no data were acquired in
these wells.
The time for each multiwell-plate acquisition varies depend-
ing on the number of fields of view successfully acquired, the
number of time gates used (seven in this case, with one being
an offset image and one providing a check against sample
motion) and the integration time for each time-gated image
(0.2 s in the case of the EGFP-only plate, 3 s for the linked
EGFP–mCherry plate and 0.2 s for the plate with both con-
structs expressed). The average FLIM acquisition times per field
of view for the EGFP-only, linked and mixed FP construct
plates (including sample motion and autofocusing) were 4.2,
23.6 and 4.1 s respectively, which give equivalent 96 field-of-
view acquisition times of 6.7, 37.8 and 6.7 min, respectively.
This FLIM FRET data set was also analysed using global fit-
ting. First, six fields of view of cells expressing EGFP only were
globally fitted using a single-exponential decay model, which
resulted in a lifetime of 2516 ps for the EGFP (t1). We then
globally fitted data from six fields of view (three from EGFP–
Figure 2. Mean fluorescence lifetime   standard deviation of histogram
([glycerol] 1% error).
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double-exponential decay model of the form [Eq. (1)]:
IðtÞ¼a1e
 t=t1 þ a2e
 t=t2 ¼ I0½a1e
 t=t1 þ a2e
 t=t2  ð1Þ
where a1 and a2 are the pre-exponential factors, a1 and a2 are
the normalised pre-exponential factors (i.e. a1+a2=1), I0 is the
initial fluorescence intensity and t1 and t2 are the fluorescence
decay times. Global fitting returned the global lifetimes of the
non-FRETing donor (t1), FRETing
donor (t2) and the fractions of
non-FRETing donor and FRETing
donor contributions (a1, a2)i n
each pixel while fixing the value
of the non-FRETing EGFP donor,
t1, to 2516 ps. This global analy-
sis was limited to data from a
total of six fields of view by the
available computer memory and
the results are shown in Table 1.
We also performed a global
double-exponential fit where
both fluorescence lifetimes were
free and in this case obtained a
slightly longer value for the non-
FRETing donor of t1=2572 ps.
For comparison, we obtained a
mean value of t=2559 ps for
the per-pixel single-exponential
fit of EGFP described above in
Figure 3.
Figure 4 shows the FRETing
population fraction, a2, calculat-
ed for three representative wells
for each of the two labelling
configurations that were fitted
using the global double-expo-
nential decay analysis. All six
images were fitted globally with
the EGFP lifetime fixed (t1=
2516 ps). It can be seen in Fig-
ure 4a that the cells expressing
the EGFP–mCherry tandem con-
struct exhibit a significant pro-
portion (47%) of the t2 compo-
nent and the mixture represent-
ed in Figure 4b shows the t1
component (i.e. EGFP alone)
dominating at  90%, which is
in agreement with the lifetime
histograms of Figure 3d. The
presence of a significant t1 com-
ponent in Figure 4a may be due
to partial expression and/or mat-
uration of the mCherry in the
tandem construct.
Figure 3. Mean well-plate lifetime maps and representative fluorescence lifetime images of live cells expressing
a) EGFP (280 fields of view acquired), b) EGFP–mCherry and EGFP (272 fields of view acquired) and c) EGFP–
mCherry (245 fields of view acquired). Black wells in (a–c) indicate that the acquisition algorithm was unable to
locate sufficient cells in these wells. d) Lifetime histograms over each whole plate (solid curves) and exemplar indi-
vidual well (dashed curves) data sets.
ChemPhysChem 2011, 12, 609–626   2011 Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim www.chemphyschem.org 615
FLIM FRET Technology for Drug Discovery2.2. Automated Multiwell-Plate FLIM Applied to Study HIV-1
Gag Oligomerisation
As an exemplar biological assay, this automated Nipkow FLIM
multiwell-plate reader was applied to FLIM FRET of HIV-1 Gag
protein oligomerisation in HIV-1 VLPs within live HEK293T cells.
The HIV-1 Gag protein has been extensively studied,
[33–38] and
here we use it to demonstrate the potential of our multiwell-
plate reader. As previously discussed, FRET provides a readout
of protein aggregation even if proteins labelled with donor
and acceptor fluorophores are expressed with a random stoi-
chiometry, since some donors and acceptors should then find
themselves in close proximity. The increase in FRET can be
measured by observing the decrease in CFP donor lifetime
when interacting with YFP acceptors in the context of the re-
sulting VLP structure.
In our first experiments we imaged a multiwell plate con-
taining HEK293T cells in which half the wells were transfected
with HIV-1 Gag–CFP (donor only), while the other half was
transfected with HIV-1 Gag–CFP and HIV-1 Gag–YFP (donor
and acceptor). The Gag–CFP fusion protein has been character-
ised in detail by numerous laboratories and it has been shown
that the presence of CFP—which, in isolation, is noted to be a
weak dimer
[61]—does not affect its normal aggregation.
[36,62–64]
These cells were grown, transfected and plated as described in
the Experimental Section. The FLIM multiwell-plate reader was
set up to excite the Gag–CFP with a supercontinuum source
and a 434/17 nm excitation filter, and the cells were imaged
through a 482/35 nm emission filter. The total acquisition time
was  7 s per well, with the whole plate being read out in ap-
proximately 11 min. Figure 5a and b show representative life-
time images of wells containing these cells, for which the FLIM
data were fitted on a per-pixel basis to a monoexponential
decay model because there were insufficient detected photons
to fit pixel-wise to a more complex profile. A modest lifetime
reduction ( standard deviation) from (2580 78) to (2470 
113) ps is observed in the average CFP donor lifetime for the
per-pixel single-exponential lifetime analysis. Figure 5c shows
the same field as Figure 5b but using global analysis to fit a
double-exponential decay to the same FLIM data. For this anal-
ysis, the lifetime of the non-FRETing donor was globally fixed
to t1=2580 ps, which was the value obtained from the single-
exponential fit to the donor-only data. This global analysis
shows that the FRETing CFP, indicated by the shorter fluores-
cence lifetime, occurs near the cell membrane where the Gag
protein is expected to aggregate
[34] and reported a global
value of t2=1586 ps.
To increase the sensitivity to changes in the CFP donor life-
time, the manually generated segmentation mask shown in
Figure 5d was applied to select only the pixels in or near the
cell membrane and to exclude pixels from the cytoplasm. Pre-
vious work has shown that up to 75% of myr(+)Gag (myr=
myristoyl group) is found in the membrane.
[36,62,65] This seg-
mentation approach causes the apparent average CFP lifetime
to decrease to (2340 90) ps and is illustrated by the green
curve in Figure 5e. To further increase the accuracy of the anal-
ysis, the spatially binned fluorescence decay from each cell
membrane was then fitted to a single-exponential decay in a
“per-ROI” analysis and Figure 5 f shows the resulting lifetime
scatter plots. The per-ROI analysis was then performed for the
entire multiwell-plate data set, which yielded an average mem-
brane CFP lifetime of (2637 99) ps (N=138) for Gag–CFP and
of (2313 155) ps (N=99) for cells co-transfected with Gag–
CFP+Gag–YFP.
To investigate this readout of Gag oligomerisation further,
we also undertook measurements of cells expressing a mutat-
ed Gag protein for which a glycine within the matrix region of
Gag was deleted. This deletion prevents the addition of a myr-
istoyl group to the N terminus of Gag, a normal post-transla-
tional modification that is thought to be necessary for Gag to
bind to the plasma membrane.
[66] Since it is at the plasma
membrane that the Gag oligomerisation is thought to take
place, the modification of Gag to make it “myristoyl group
Table 1. Results of global analysis of cells expressing EGFP, EGFP–mCher-
ry and both EGFP and EGFP–mCherry. Six EGFP fields of view were global-
ly fitted using a single-exponential decay (top row). The resulting lifetime
(t1) was then fixed for the subsequent global double-exponential decay
analysis (bottom two rows).
Mean
a1
Global t1 Mean
a2
Global t2
EGFP only 1.00 2516 N/A N/A
EGFP–mCherry construct 0.53
2516
(fixed)
0.47
1068
(fitted)
EGFP and EGFP–mCherry con-
structs
0.90 0.10
N/A: not applicable.
Figure 4. Fraction of FRETing donor population, a2, calculated using a global
double-exponential fit with EGFP component fixed (t1=2516 ps) for cells ex-
pressing a) EGFP–mCherry only and b) EGFP and EGFP–mCherry.
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provide a biological control for Gag aggregation at the plasma
membrane. The lack of aggregation at the membrane for
myr( )Gag was confirmed by confocal microscopy (data not
shown).
A multiwell map plate of cells expressing a variety of combi-
nations of Gag–CFP, myr( )Gag–CFP, Gag–YFP and
myr( )Gag–YFP is shown in Figure 6a. This multiwell plate was
imaged in an average of 9 s per well, which corresponded to
reading the whole plate in just over 14 min. As described
above, each cell was manually segmented to extract only
pixels near to the plasma membrane where FRET is expected
to occur. For cells expressing Gag–CFP and Gag–YFP, we ob-
serve a significant decrease in donor lifetime and this can be
seen in both Figure 5 and Figure 6. The changes in lifetime ob-
served in the other columns are consistent with the deletion
of the first glycine in the matrix portion of Gag preventing
myristoylation and therefore inhibiting membrane association
and oligomerisation of this protein. More specifically, for cells
expressing myr( )Gag–CFP and myr( )Gag–YFP we expect
almost no Gag protein binding at the plasma membrane and
so this acts as a biological control for negligible FRET (columns
1 and 2 of Figure 6c). It is expected that a small fraction of
membrane-bound Gag–CFP could dimerise with myr( )Gag–
YFP leading to FRET, although we believe this effect to be
small since no significant difference is observed compared to
Gag–CFP alone (columns 3 and 4 of Figure 6c). The lifetime of
Gag–CFP can also be modified by homoFRET or refractive
index effects at the membrane, as discussed below.
We note that both Gag and myr( )Gag and are believed to
be able to dimerise in the cytosol and we therefore could
expect the cytosolic Gag proteins to also present reduced CFP
lifetimes due to FRET. In the case of myr(+)Gag transfected
cells, the image segmentation to select only the region corre-
sponding to the cell membrane will mean that the detected
signal is predominantly from membrane-bound protein due to
its higher concentration. In the case of myr( )Gag transfected
cells, the signal from a similar membrane ROI should be pre-
dominantly from cytosolic protein and one would therefore
also expect to see a decrease in lifetime for the cells transfect-
ed with both myr( )Gag–CFP and myr( )Gag–YFP compared
to just myr( )Gag–CFP. A small decrease is observed between
columns 1 and 2 of Figure 6c, although it is not statistically
significant. This suggests that the dimerisation of the cytosolic
Gag protein is weak compared to the multimerisation at the
membrane.
It is interesting to note that, although the cells expressing
myr( )Gag–CFP show a lifetime that is consistent with previ-
ously reported values for CFP, the cells expressing the normal
Gag–CFP construct show a reduced lifetime, where the majori-
ty of their fluorescence is observed at the membrane. This life-
time reduction is most likely to be due to the formation of
VLPs that concentrate the Gag–CFP molecules in close proximi-
ty at the membrane. It has previously been shown that the life-
time of CFP, with its multiple fluorescing components, can be
decreased by homoFRET as well as by the effect of refractive
index change at the membrane.
[67] A further factor could be an
Figure 5. a,b) Fluorescence lifetime images of HEK cells with HIV virions ex-
pressing a) Gag–CFP only and b) Gag–CFP and Gag–YFP in an unknown
ratio. c) Map showing the fraction of the short-lifetime component
(t2=1586 ps) obtained from globally fitting a double-exponential decay
across the whole field of view with the first component fixed to 2580 ps.
d) Image segmentation mask manually generated from the fluorescence in-
tensity image in (b). e) Mean lifetime histograms corresponding to all pixels
from 48 Gag–CFP-only wells (blue line), to all pixels from 47 Gag–CFP/Gag–
YFP wells (red line) and to only pixels included in the manual segmentation
mask over all 47 Gag–CFP/Gag–YFP wells (green line). f) The per-ROI lifetime
analysis of all cells in all wells, that is, each membrane region is segmented
and binned to produce a single decay profile, which is then fitted with a
single-exponential decay model to calculate the mean lifetime.
ChemPhysChem 2011, 12, 609–626   2011 Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim www.chemphyschem.org 617
FLIM FRET Technology for Drug Discoveryinteraction of HIV-1 Gag with host cell proteins, of which Teth-
erin and Tsg101 are potential candidates. The lifetime reduc-
tion of CFP by homoFRET is associated with the presence of
the multiple CFP species that result in its complex decay pro-
file, and should not be observed if a monoexponential decay-
ing fluorophore could be employed. We are therefore working
to replace CFP with teal fluorescent protein (TFP)
[68] or mTur-
quoise,
[69] which we believe will facilitate more quantitative
readouts of FLIM and FRET.
2.3. Multiplexed Optical Sectioned FLIM Readouts
We demonstrated the capabilities of our optically sectioned
multiplexed FLIM microscope by interleaved time-lapse imag-
ing of live cells simultaneously labelled with two calcium
probes following stimulation with 20 mm ionomycin and
12 mm calcium solutions. HEK293 cells were transfected with
the genetically expressed biosensor TN-L15, for which changes
in calcium levels are read out by FRET between the CFP and
Citrine fluorophores, and also with a calcium-sensing dye, GFP-
Certified FluoForte, which is conventionally read out using its
fluorescence intensity. The emission profile of the latter is spec-
trally separate from those of CFP and Citrine, thus making it
useful for multiplexing with the many CFP/YFP FRET biosensors
that are available. As well as the change in fluorescence inten-
sity with variations in calcium concentration, the fluorescence
lifetime of GFP-Certified FluoForte also changes. We are still in
the process of characterising the fluorescence lifetime readout
of this probe, which we will publish in detail elsewhere, but it
serves here to illustrate the ability to acquire FLIM data in two
channels. Figure 7 shows the series of fluorescence lifetime
images acquired in each channel following stimulation by
ionomycin.
In a similar manner to the work of Wilms and Eilers
[70] using
different calcium dyes, we applied a double-exponential decay
model to describe the fluorescence decay profile of GFP-Certi-
fied FluoForte corresponding to a mixture of unbound and cal-
cium-bound dye molecules. Due to the limited fluorescence
signal available, which was constrained by photobleaching
considerations, we applied global fitting, for which the two
lifetime components (t1 and t2) were linked across the whole
FLIM time series. The fitting algorithm returned values of t1=
3139 and t2=588 ps, which we attribute to the bound and un-
bound states of the dye, respectively; the results of this analy-
sis are shown in Figure 7b. The FLIM map pre-stimulation
(0 min) shows a significantly shorter lifetime than the post-
stimulation FLIM maps, as can also be seen in the associated
histograms and plots of mean lifetime. The error bars on the
plots of mean lifetime (right-hand plot in Figure 7b) are the
standard deviation of the lifetime distribution, and so indicate
both the variation in lifetime due to photon statistics as well
as spatial variation in lifetime across each image. Therefore
these error bars represent an upper limit on the uncertainty of
the measured mean lifetime.
For the TN-L15 data, the fluorescence decay of CFP is known
to have a complex exponential decay profile and this greatly
complicates the data analysis. As an initial approximation, we
chose to fit a single-exponential decay to each pixel to esti-
mate the mean fluorescence lifetime, as shown in Figure 7c. A
significant decrease in fluorescence lifetime of the TN-L15 FRET
Figure 6. a) Map of measured mean per-ROI CFP lifetimes, b) multiwell-plate
map and c) plot of per-ROI CFP lifetimes for assay of aggregation of a range
of different HIV Gag proteins.
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S. Kumar et al.Figure 7. Multiplexed FLIM of calcium sensors. a) Overlay of intensity images of CFP in TN-L15 (blue) and GFP-Certified Fluoforte (red). b) FLIM images of GFP-
Certified Fluoforte at selected time points of the measurement. Below the images are histograms of the average lifetimes (left) and the time variation of the
mean lifetime (right). c) FLIM images of CFP in TN-L15 obtained using a single-exponential fit, which represent the average lifetimes at selected time points
of the measurement. The graphs show the corresponding lifetime histograms (left) and the time variation of the mean lifetime (right). d) The same data as in
(c) but instead fitted using a global analysis in which the ratio of the pre-exponential decay parameters is fitted as a global parameter across the whole FLIM
time series (see text). The graphs show histograms of the average lifetimes (left) and the time variation of the mean lifetime (right). All images were analysed
using 4 4 binning.
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1 min post stimulation. For comparison, we also performed a
global analysis of the TN-L15 data. We made the assumption
that the CFP chromophore exists in two different species—
each with different lifetimes—and that the ratio of these two
species is maintained throughout the experiment. We there-
fore performed a global analysis in which the ratio of the two
species remained constant over the whole time series. This ap-
proach yielded the same trend as the single-exponential decay
approximation although it provided slightly different values for
the average lifetime.
We believe that all these readouts and analyses are consis-
tent, and demonstrate that the stimulation of the cells by iono-
mycin and the consequent increase of intracellular calcium
levels have resulted in changes in fluorescence lifetime of both
the CFP donor in the TN-L15 FRET construct and the calcium-
sensing dye that our system has been able to follow. This tech-
nique may be extended to two multiplexed FLIM readouts of
spectrally distinct FRET biosensors, which utilise fluorophores
such as the combination of CFP/YFP and TagRed/mPlum re-
ported in our previous paper.
[41] We would caution against the
use of fluorophores such as CFP, however, which present com-
plex exponential decay profiles and can lead to fluorescence
lifetime artefacts, for example due to differential photobleach-
ing of different species or to difficulties in fitting such complex
decay data. It is clearly desirable to work with donor fluoro-
phores exhibiting monoexponential decay profiles, although
we note that these are relatively uncommon and that even
EGFP exhibits a contribution ( 10%) from a second compo-
nent.
[71] Unfortunately, most FRET biosensors reported to date
utilise the CFP/YFP FRET pair and so we believe that it is highly
desirable to clone new variants with monoexponential donors
such as mTurquoise.
[69] For multiplexed readouts, it is impor-
tant to develop FRET probes
that emit in spectral windows
distinct from those of CFP/YFP. It
would also be interesting to take
advantage of “dark” acceptors
such as REACH,
[42] which can
help minimise spectral crosstalk.
2.4. Tomographic FLIM Using
Optical Projection Tomography
Tomographic FLIM of transparent
samples has been implemented
using the OPT set-up described
in the Experimental Section. OPT
was originally developed as a
tool for 3D imaging of approxi-
mately millimetre- to centimetre-
scale samples such as mouse
embryos, and Figure 8a shows a
FLIM-OPT image of a mouse
embryo that has been optically
cleared using BABB, fixed in
formaldehyde and the neurofila-
ments labelled with an Alexa-488-conjugated antibody.
[45]
Upon spectrally filtered supercontinuum excitation at (485 
10) nm and tomographic image reconstruction, the Alexa-488-
labelled neurofilaments presented a lifetime of (1360 180) ps
and autofluorescence, observed in the unlabelled heart and
dorsal aorta, presented a fluorescence lifetime of (1030 
135) ps. The data acquisition entailed acquiring time-gated
images at 360 projection angles, which required a total of
800 s. This timescale compares favourably to that required to
obtain 3D image data by conventional serial sectioning and se-
quential imaging of extended samples, such as tissue biopsies,
and FLIM-OPT appears to have potential as a tool for histopa-
thology. Figure 8b shows a 3D fluorescence lifetime image of a
cleared but unstained sample of lung tissue, for which the life-
time contrast is provided by the tissue autofluorescence. This
label-free optical sectioning approach may find applications
where 3D histopathology is required.
Autofluorescence can also be exploited for label-free con-
trast in plant samples. Figure 8c shows a 3D fluorescence life-
time image of a cleared but unstained silique from an Arabi-
dopsis plant in which the fluorescence lifetime clearly contrasts
the silique and seeds. As already discussed, while the optical
clearing process is necessary for OPT and is generally compati-
ble with fluorescence labelling, it is found to degrade the sig-
nals from fluorescent proteins. We are currently working to de-
velop tomographic FLIM readouts of FRET and Figure 8d illus-
trates a proof-of-principle FLIM FRET OPT experiment, showing
a 3D fluorescence lifetime image of a (transparent) silicone
phantom with two wells containing cytosolic preparations of
HEK293T cells expressing the calcium sensor, TN-L15. CaCl2 was
added to one of the wells, which resulted in an increased FRET
signal, as indicated by the 550 ps difference in fluorescence
lifetimes. This motivates us to apply FLIM to read out FRET sen-
Figure 8. 3D FLIM-OPT images of a) mouse embryo with Alexa-488-labelled neurofilaments; b) cleared but un-
stained ex vivo tissue section; c) cleared but unstained silique of Arabidopsis; d) wells containing cytosol prepara-
tions of TN-L15 with CaCl2 added to the right-hand well; and e) fixed but not cleared FLI:GFP zebrafish. AF=auto-
fluorescence.
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unfortunately the chemical clearing process often precludes
the use of fluorescent proteins unless they can be re-labelled
post-clearing, for example, by using an antibody to the fluores-
cent protein. Fortunately, however, we have recently observed
that at 3 days post-fertilisation, zebrafish embryos are suffi-
ciently transparent for the direct application of (FLIM) OPT. Fig-
ure 8e shows a 3D fluorescence lifetime image of a fixed but
uncleared transgenic (FLI:GFP) zebrafish in which the vascula-
ture is genetically labelled with EGFP. Autofluorescence from
the yolk sack is also apparent with lifetime contrast. We are
currently working to extend this to FLIM-OPT of live zebrafish
and believe that this will create many new opportunities to
use FLIM FRET to study cell-signalling pathways for drug dis-
covery and biomedical research.
2.5. Microconfocal FLIM Endoscopy
To demonstrate the potential of confocal FLIM endomicrosco-
py for imaging spatiotemporal dynamics of cell-signalling pro-
cesses, we applied it to a FRET model in live COS-7 cells that
were transfected with EGFP or an EGFP–mCherry tandem FRET
construct. Figure 9 shows the optically sectioned FLIM images
acquired, with the corresponding lifetime histograms, using
the confocal FLIM endomicroscope to image the cells in cul-
ture. The FLIM data were fitted to a single-exponential decay
model and the clear decrease in the lifetime of the EGFP
donor expected for FRET in the tandem construct is apparent.
The data for Figure 9a and b were acquired in 2 s and analysed
with 5 5 pixel binning (SPCImage binning factor=2) of the
FLIM data. This acquisition time is approaching that compati-
ble with in vivo and time-lapse imaging and we are now work-
ing towards demonstrating FLIM FRET readouts in live subjects.
In the future, we hope to reduce the effects of sample motion
during in vivo FLIM acquisition through the use of “FIFO” FLIM
combined with software-based detection and correction of
image motion during the acquisition. We note that there is a
trade-off between image speed and spatial resolution that
should be optimised for specific applications.
3. Conclusions
Our intention has been to demonstrate the broad applicability
of FLIM to read out FRET in a range of applications across the
spectrum of the drug-discovery pipeline. FLIM FRET is well es-
tablished in microscopy where it has almost become a stan-
dard tool to study biomolecular interactions. To date, however,
there has been limited translation to high-throughput assays
or to in vivo imaging. We have demonstrated that it is possible
to construct an automated FLIM multiwell-plate reader that
can acquire optically sectioned lifetime images of fixed and
live cells labelled with fluorescent proteins in a few seconds
per field of view and read an entire 96-well plate in less than
 15 min. Although our time-gated imaging instrumentation
utilises relatively long time gates of 2–3 ns duration to maxi-
mise the number of detected photons, it is still capable of de-
termining fluorescence lifetimes of less than ~100 ps and of re-
solving lifetime differences of ~20 ps. Using global analysis,
the system can accurately determine the ratio of contributions
from different lifetime components, which may be used to
quantify mixtures of fluorophores or to calculate the fraction
of donor molecules undergoing FRET.
As an exemplar application, we have applied this instrument
to study the aggregation of HIV-1 Gag proteins in VLP forma-
tion at the cell membrane, which is challenging because the
unknown stoichiometry of the fluorescent protein expression
can mean that the average change in the donor fluorescence
lifetime over the field of view is rather low, that is, a few hun-
dred picoseconds. The FLIM readout of this FRET assay can be
improved by the use of image segmentation and global analy-
sis such that the expected change in CFP lifetime for an assay
of compounds inhibiting Gag protein aggregation at the mem-
brane would be closer to 350 ps.
The information available from FLIM FRET studies of cell-sig-
nalling networks could be further enhanced by multiplexing
readouts, for example, of multiple protein interactions. While
most FLIM and FRET experiments are applied to study a single
component of a cell-signalling network, we have shown that
multiplexed FLIM can be applied to read out changes in the
lifetime of two fluorophores in a single time-lapse acquisition.
We aim to implement this facility in our automated FLIM multi-
well-plate reader where it could provide increased specificity
for screens and systems biology.
While there are many alternative approaches to read out
FRET of protein interactions, the robust nature of fluorescence
lifetime measurements makes FLIM an attractive approach to
translate cell-based assays to live organisms. We have shown
Figure 9. Confocal FLIM endomicroscopy images of COS-7 cells expressing
a) EGFP and b) EGFP–mCherry tandem FRETconstruct; c) the corresponding
fluorescence lifetime histograms.
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thus permitting signalling processes in cells to be studied in
vivo in intact animals. This could permit longitudinal studies in
mammals, greatly reducing the numbers of animals required
for testing, for example for drug discovery, and improving the
value of the multiple readouts compared to measurements on
multiple animals sacrificed at different endpoints. Further re-
duction in the numbers of such animal tests may be achieved
if more physiological data can be obtained from assays in sim-
pler organisms such as zebrafish. There is increasing interest in
such assays, and technology for automated high-throughput
imaging of zebrafish is being developed.
[72] We have demon-
strated the first FLIM of fluorescent proteins in zebrafish and
shown that (FLIM) OPT can be applied without chemical clear-
ing. This opens the path to FLIM-OPT of live zebrafish for FRET
readouts of spatiotemporal dynamics of signalling networks in
vivo.
Experimental Section
The FLIM and FRET data presented here was obtained using wide-
field time-gated imaging and laser scanning TCSPC.
[21] The time-
gated imaging was implemented using gated optical image inten-
sifier (GOI) technology, for which we have recently characterised
the signal-to-noise performance.
[73] In order to accurately fit the
fluorescence decay data, temporal IRFs were recorded using solu-
tions of DASPI or erythrosin B, which have fluorescence lifetimes
shorter than 150 ps. These FLIM techniques were implemented in
the following instruments:
Automated Nipkow FLIM Multiwell Plate Reader: Figure 10 presents
the optical and electronic configurations of the FLIM multiwell
plate reader, which is based on a commercial plate reader (IN Cell
Analyzer 1000, GE Healthcare) that is built around a wide-field mi-
croscope and incorporates an optical autofocus module and mo-
torised sample stage.
To implement optically sectioned FLIM, we utilised the high-speed
Nipkow FLIM instrumentation described in Grant et al.
[27] but incor-
porated a newly available Nipkow disc head (Yokogawa, model
CSU-X M1L) that provides improved light efficiency, particularly of
the excitation radiation, compared to the unit (Yokogawa CSU-10)
used previously.
[27,28] Because the Nipkow unit is self-contained
with respect to the excitation and fluorescence light paths, it is
straightforward to implement via a camera port of a wide-field mi-
croscope. This FLIM multiwell plate reader was controlled by in-
house software written in LabVIEW (National Instruments) that au-
tomatically moves the well plate, focuses the microscope, finds
cells and can set the FLIM acquisition parameters in a manner simi-
lar to our previous automated plate reader.
[28] Excitation was pro-
vided by a frequency-doubled femtosecond Ti:Sapphire laser
(Spectra-Physics, model Tsunami) or by a fibre-laser-pumped super-
continuum source (Fianium UK Ltd, SC400-6) that produces ~10 ps
pulses at 60 MHz repetition and ~2m Wn m
 1 average spectral
power density with sufficient spectral coverage to excite CFP, YFP
and mCherry etc. Electronically controlled wavelength selection
was implemented using a motorised filter wheel. Time-gated imag-
ing was provided by a gated optical intensifier (Kentech Instru-
ments, model HRI) that was customised to provide time-gates as
long as 3 ns. This was read out using a cooled CCD camera (Hama-
matsu Photonics, model ORCA-ER). The HRI was operated with 2–
3 ns-wide gates triggered at various delay times after the excita-
tion pulses to temporally sample the fluorescence decay profiles
for each pixel in the field of view. Typically ~7 gate delays, with
~1 s CCD integration time at each delay, are used to sample fluo-
rescence from labelled cells. A PicDem circuit (Microchip Technolo-
gy, Inc.) was used to provide a trigger for the CCD camera and can
also be used to control a shutter that blocks the excitation beam
between acquisitions in order to minimise photobleaching.
For automated image acquisition, the user inserts the multiwell
plate sample array, selects which wells to image and sets the delay
of the initial time gate with respect to the excitation pulses and an
intensity threshold for the cell seeking routine. In order to mini-
mise the time required to read a multiwell plate we used a “pre-
scan” mode, which uses a seek algorithm to find specific number
of fields of view that have a predetermined fraction of pixels
above a given threshold. This information is used when we then
run a “full scan” to acquire the desired FLIM data. It is also possible
to undertake a rapid FLIM prescan, acquiring only two or three
time-gates per image, in order to automatically determine the
delays of the time-gates sampling the fluorescence decay profiles
for the full scan.
Following the automated data acquisition, fluorescence data were
fitted to decay models that were convolved with the temporal in-
strument response function (IRF) using in-house software written
in LabVIEW (National Instruments) designed to provide fluores-
cence lifetime maps and fluorescence intensity images (calculated
by integrating under the decay curve). We typically represent fluo-
rescence lifetime data in fluorescence lifetime “images” for which a
false colour scale encodes the lifetime parameter and the bright-
ness encodes the total fluorescence intensity. We note that incor-
porating an appropriate IRF in the fitting procedure is essential for
accurate fitting of complex decay profiles. Our global fitting pro-
gramme can also take account of incomplete fluorescence decays
at the arrival of the “next” excitation pulse. This software is able to
automatically batch-process the data from multiple wells.
Figure 10. Schematics of a) optical and b) electronic configurations of an op-
tically sectioned FLIM multiwell plate reader based on a modified IN Cell
1000 Analyser.
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with seven time gates and, for an average excitation power of less
than 1 mW at the sample, acquisition times are typically <10 s per
image, permitting us to read a 96-well plate in less than 20 mi-
nutes and deliver fluorescence lifetime images fitted pixelwise to
monoexponential decay profiles. These image acquisition times are
often too short to record sufficient photons to accurately fit com-
plex exponential decays on a pixel by pixel basis. When we wish to
analyse our data with respect to complex decay models, we can
either increase the image acquisition times to 10–100 s per field of
view in order to detect sufficient photons per pixel or we can ac-
quire fluorescence data as for monoexponential decay fits and
apply image segmentation and binning to reach a sufficient
number of detected photons. Alternatively, we can apply “global
fitting”, with or without image segmentation, to derive parameters
from complex decay models with a similar number of detected
photons per pixel as is required for fitting to monoexponential
decay models.
Our in-house image segmentation and global fitting software is
written in C++ with a MATLAB front end and will be described in
detail in a future publication. We note that traditional nonlinear fit-
ting approaches are not appropriate for global fitting of FLIM data
as the number of non-linear parameters is of the order of the
number of pixels, which is generally rather large. To make the
global analysis problem computationally tractable we use a Varia-
ble Projection algorithm as described by Kaufman
[74] and discussed
further by Golub and Pereyra
[75] combined with a standard Leven-
berg–Marquardt nonlinear least squares (NLLS) solver. We first note
that the expression for a multiexponential decay as described by
Equation (1) may be expressed as a linear combination of nonlinear
functions (i.e., the exponential functions). For the global analysis
problem the nonlinear functions depend only on the lifetimes and
so are constant across the image. For a given set of nonlinear pa-
rameters, the linear parameters (the pre-exponential factors) may
be determined by solving a set of linear equations; since the pre-
exponential factors for a given pixel only depend on the data re-
corded in that pixel, the linear least squares problem may be parti-
tioned into a set of independent small least-squares problem for
each pixel. Exploiting this knowledge, we may reduce the dimen-
sionality of the NLLS problem to the number of exponentials. We
use a modified version of the Variable Projection algorithm imple-
mented by LeVeque (http://www.netlib.org/opt/varpro) adjusted
such that the memory requirements scale linearly rather than
quadratically with the number of pixels. It should be noted that
the main computational burden of traditional pixel-by-pixel NLLS
fitting of FLIM data lies in the calculation of the model function at
each iteration. Therefore, since the global implementation as de-
scribed only evaluates the model function once per iteration for
the entire image, it is significantly less computationally intensive
that the pixel-by-pixel approach. The memory requires are higher
as all pixels must be kept in memory simultaneously. As an exam-
ple, a global fit across six images in the GFP-mCherry data shown
in Table 1 took 0.5 s on a workstation with a 2.9 GHz Intel Core i7
processor while using 400 Mb of memory for data processing.
Multiplexed Optically Sectioned FLIM Microscope: This microscope
utilised essentially the same experimental setup as described in
ref. [27] except that the manually configurable Nipkow disc unit
(Yokogawa CSU-10) was replaced by the newly available Nipkow
disc unit (Yokogowa, model CSU-X A3) that provides improved
light efficiency and electronic switching of the dichroic beam split-
ters (Figure 11). By introducing electronically controlled filter
wheels for the excitation and emission pathways and synchronis-
ing these to the dichroic changer and the FLIM acquisition hard-
ware, we were able to automatically switch excitation and detec-
tion wavelengths in order to image different fluorophores. For ex-
citation we used a fibre laser-pumped supercontinuum source (Fia-
nium Ltd, model SC450-6) and a frequency-doubled femtosecond
Ti:Sapphire laser (Spectra-Physics, model Tsunami). The computer-
controlled hardware was able to switch between configurations
optimised for different fluorophores in about one second, enabling
us to acquire interleaved series of time-gated FLIM acquisitions.
Thus, we were able to multiplex two FLIM readouts, sequentially
acquiring interleaved time-lapse FLIM data. This can be applied to
read out, for example, two FLIM FRET measurements of FRET bio-
sensors or intermolecular FRET reporting protein–protein interac-
tions.
FLIM OPT Instrumentation: Figure 12 shows a schematic of the ex-
perimental setup for wide-field time-gated tomoFLIM. The sample
is suspended beneath an electronically controlled rotation stage in
a reservoir of index matching fluid. A fibre laser-pumped super-
continuum source (Fianium SC 450-6) was used to excite the fluo-
rescence, which was imaged onto the GOI of a wide-field time-
gated imaging system and the resulting time-gated and intensified
fluorescence signals were recorded by a CCD camera, in a similar
manner described earlier for FLIM.
It is also possible to record the transmitted excitation radiation in
order to reconstruct a 3D map of the absorption at the excitation
wavelength. The sample is rotated about the Z axis and typically a
series of time-gated images are recorded at regular intervals over a
full 3608 rotation for each setting of the time gate delay. 3D maps
of fluorescence intensity and lifetime are then reconstructed using
Figure 11. Experimental setup for multiplexed optically sectioned FLIM mi-
croscopy.
Figure 12. Schematic of the experimental configuration for FLIM OPTstud-
ies.
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[76] At each value of the time gate delay, a
1D Fourier transform is applied to each projection in a particular
X–Y plane of the sample and the resulting functions are then fil-
tered in the Fourier domain to account for unequal sampling of
the spatial frequency components. The inverse Fourier transform is
then applied and the resultant filtered projections are backproject-
ed at the corresponding angle to reconstruct the X–Y (time-gated)
intensity distribution of the sample in that plane. The fluorescence
lifetimes are then calculated in the usual way by fitting the series
of time-gated fluorescence intensity images to an appropriate
decay model at each X–Y plane to obtain the fluorescence lifetime
map or image for that plane. To visualise the whole sample, we
typically use 3D rendering software (Volocity Visualisation, Per-
kinElmer) applied to the Z-stack of fluorescence lifetime images.
Confocal FLIM Endomicroscope: The confocal FLIM endomicroscope
(Figure 13) was based on a commercially available endomicroscope
(Cellvizio  GI, Mauna Kea Technologies), which is a laser scanning
single-photon fluorescence fibre bundle endomicroscope that is
capable of recording optically sectioned images with a variety of
fibre probes. For the experiments reported here, we used a coher-
ent bundle containing 30 000 optical fibre cores that was terminat-
ed with a miniature objective (Cellvizio  Mini O). The probe has a
lateral resolution of ~1.4 mm, a working distance of 60 mm and a
field of view of 240 mm. The diameter of the distal tip is 2.6 mm.
For FLIM of live cells labelled with EGFP, excitation pulses centred
at 481 nm from a fibre-delivered mode-locked frequency-doubled
Ti:Sapphire laser (Spectra Physics, model Mai-Tai) were coupled
into the internal beam path of the endoscope immediately before
the scanning assembly and the descanned fluorescence was fo-
cussed through a pinhole onto a photomultiplier that was con-
nected to the TCSPC card (SPC830, Becker & Hickl GmbH) for
FLIM.
[53] A 505 nm dichroic filter was used in combination with a
520–550 nm bandpass emission filter to select the fluorescence
from the EGFP. The internal resonant scanner was operated in bi-
directional mode, resulting in two mirrored images—one for each
scan direction. A single interlaced image was produced with an au-
tomated procedure using the cross correlation of the two images
to provide a final output image size of up to 350 x 512 pixels,
which is limited by the TCSPC card memory. For faster imaging,
the FLIM data could be binned to increase the effective number of
photons for fitting. The line and frame synchronization signals
were obtained from the endoscope electronics and the pixel clock
(300 ns period) was derived from the TSCPC card. FLIM images
were calculated using SPCImage (Becker and Hickl, GmbH) from
TCSPC data obtained for exposure durations varying from 0.2 to
60 s with an average power of 360 mW over the field of view,
which resulted in a typical pixel count rate of ~3–7 x
10
5 countss
 1.
Sample Preparation: Dye Samples: The dye mixtures of Rhoda-
mine B and Rhodamine 6G were prepared by dissolving pure dye
powder into spectral grade methanol and then subsequent dilu-
tion in MilliQ purified water (Millipore, Billerica, USA) to give a final
10 mm solution of each dye. The Rhodamine B and Rhodamine 6G
solutions were mixed in ratios of 100:0, 80:20, 60:40, 40:60, 20:80
and 0:100 and imaged using the automated Nipkow FLIM multi-
well plate reader, which used a 40x CFI PLAN Fluor ELWD 0.60 NA
objective (Nikon, Tokyo, Japan)
and a Di01-T488/532 dichroic
beamsplitter (Semrock, Rochester,
USA). The dataset was acquired
using six time-gated images with a
width of 2000 ps. Analysis of life-
time data was conducted using an
in-house lifetime fitting software
as described above.
The DASPI samples in a composite
solvent were prepared by the vigo-
rous mixing of glycerol and etha-
nol, followed by the addition of
DASPI (prepared by dissolving
DASPI powder into spectral grade
methanol) and further vigorous
mixing. These samples were
imaged with a 465/30 nm excita-
tion filter, a Di01-T488 dichroic
beamsplitter and a 525/50 nm
emission filter (Semrock, Rochester,
USA).
Cell Culture and Transfection Sys-
tems: HEK293T and COS-7 cells were grown as a monolayer at
378C, 5% CO2 in DMEM (Gibco, Invitrogen) with high glucose and
supplemented with 10% fetal bovine serum and 0.5% penicillin/
streptomycin.
For Gag expression, HEK293T cells were seeded the day prior to
transfection, in 25 cm
2 flasks and grown overnight until >70%
confluent. The following day, transfections were carried out using
Effectene transfection reagent (Qiagen, Germany) following the
manufacturer’s protocol. Cells were incubated with the transfection
mixture for eight hours at 378C, 5% CO2, then washed with phos-
phate buffer, trypsinized, plated into 96 well plates, and incubated
in fresh media at 378C, 5% CO2 until next day, when they were
imaged.
For EGFP and EGFP-mCherry constructs, transient transfection was
used for the HEK293T cells. 20 ml of the transfection mixture was
added to each well of the plate and 175 ml of cells were laid on
top of the transfection mixture. The plate was then incubated
overnight at 378C and 5% CO2. Before imaging, the media was re-
moved, the cells were washed with phosphate buffer and Hank’s
balanced salt solution was added. COS-7 cells used for microconfo-
Figure 13. Schematic of a confocal FLIM endomicroscope with inset photograph of the instrument mounted on a
clinically deployable trolley.
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Petri dishes and transfections were carried out using Effectene.
Images were taken the following day.
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